ABOUT THIS EVENT
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Doug Onsi, Chief Financial Officer of Leap Therapeutics, rang the Closing Bell.